Medical specialists from France tagged as investigators in clinical trials studying Stevens-Johnson Syndrome/toxic Epidermal Necrolysis

Total 4 results

Anne-Claire LUKASZEWICZ, MD
Seen in:
- LYON cedex 03, Département d'Anesthésie-Réanimation , Hôpital Edouard Herriot, Hospices Civils de Lyon
Trials:
- NCT04651439 (Principal Investigator)
Conditions:
- Rare Diseases;
- Toxic Epidermal Necrolyses
Benoit BEN SAID, MD
Seen in:
- Lyon, Reference center for toxic bullous dermatoses and severe drug eruptions, Edouard Herriot Hospital, Hospices Civils de Lyon
Trials:
- NCT04651439 (Principal Investigator)
Conditions:
- Rare Diseases;
- Toxic Epidermal Necrolyses
Solène POUTREL, MD
Seen in:
- Lyon, Service de Médecine Interne, Hôpital Edouard Herriot, Hospices Civils de Lyon
Trials:
- NCT04651439 (Principal Investigator)
Conditions:
- Rare Diseases;
- Toxic Epidermal Necrolyses
Véronique LERAY, MD
Seen in:
- LYON cedex 03, Département d'Anesthésie-Réanimation , Hôpital Edouard Herriot, Hospices Civils de Lyon
Trials:
- NCT04651439 (Sub-Investigator)
Conditions:
- Rare Diseases;
- Toxic Epidermal Necrolyses

Clinical Trials on Stevens-Johnson Syndrome/toxic Epidermal Necrolysis

University of Liege

Completed

G-CSF in the Treatment of Toxic Epidermal Necrolysis (NeupoNET)

Stevens - Johnson Syndrome

Belgium
Centre Hospitalier Universitaire Vaudois

Completed

Nutritional and Metabolic Management of Toxidermia Patients Requiring Intensive Care (TEN Metabolism) (TEN metabolism)

Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum
Vanderbilt University Medical Center
University of Toronto; University of Ottawa

Recruiting

NATIENS: Optimal Management and Mechanisms of SJS/TEN (NATIENS)

Stevens-Johnson Syndrome | Toxic Epidermal Necrolyses

United States
James Chodosh, MD, MPH
Massachusetts Eye and Ear Infirmary; Fonds de recherche en ophtalmologie de...

Withdrawn

Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

Stevens-Johnson Syndrome | Mucous Membrane Pemphigoid | Toxic Epidermal Necrolysis (Lyell) Syndrome

United States, Canada
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

LYell SYndrome MEsenchymal Stromal Cells Treatment (LYSYME)

Mesenchymal Stromal Cells | Lyell Syndrome | Overlap Syndrome | Toxic Epidermal Necrolysis | Epidermal Necrolysis | Adipose Derived Stromal Cells
Sechenov University
Pirogov Russian National Research Medical University

Recruiting

Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian Population

Bullous Pemphigoid | Stevens-Johnson Syndrome | Toxic Epidermal Necrolyses | Pemphigus

Russian Federation
Hospices Civils de Lyon

Recruiting

Severe Bullous Drug Eruption and Filgrastim (GNET)

Rare Diseases | Toxic Epidermal Necrolyses

France
Brett King
Swedish Orphan Biovitrum

Terminated

Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis

Stevens-Johnson Syndrome | Toxic Epidermal Necrolysis

United States
Loyola University

Withdrawn

Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)

Toxic Epidermal Necrolysis
University of California, Davis

Withdrawn

Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis (TEN)

Toxic Epidermal Necrolysis

United States

Medical specialists from France tagged as investigators in clinical trials studying Stevens-Johnson Syndrome/toxic Epidermal Necrolysis

Clinical Trials on Stevens-Johnson Syndrome/toxic Epidermal Necrolysis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations